QIAGEN Total Assets 2006-2021 | QGEN

QIAGEN total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • QIAGEN total assets for the quarter ending March 31, 2021 were $5.763B, a 11.23% increase year-over-year.
  • QIAGEN total assets for 2020 were $5.913B, a 12.93% increase from 2019.
  • QIAGEN total assets for 2019 were $5.236B, a 8.92% decline from 2018.
  • QIAGEN total assets for 2018 were $5.748B, a 14.09% increase from 2017.
QIAGEN Annual Total Assets
(Millions of US $)
2020 $5,913
2019 $5,236
2018 $5,748
2017 $5,039
2016 $4,308
2015 $4,179
2014 $4,454
2013 $4,088
2012 $4,088
2011 $3,730
2010 $3,914
2009 $3,796
2008 $2,885
2007 $2,775
2006 $1,212
2005 $765
QIAGEN Quarterly Total Assets
(Millions of US $)
2021-03-31 $5,763
2020-12-31 $5,870
2020-09-30 $5,771
2020-06-30 $5,295
2020-03-31 $5,181
2019-12-31 $5,236
2019-09-30 $5,143
2019-06-30 $5,383
2019-03-31 $5,420
2018-12-31 $5,748
2018-09-30 $5,299
2018-06-30 $5,309
2018-03-31 $5,105
2017-12-31 $5,039
2017-09-30 $5,097
2017-06-30 $4,556
2017-03-31 $4,068
2016-12-31 $4,308
2016-09-30 $4,328
2016-06-30 $4,119
2016-03-31 $4,120
2015-12-31 $4,179
2015-09-30 $4,159
2015-06-30 $4,131
2015-03-31 $4,170
2014-12-31 $4,454
2014-09-30 $4,461
2014-06-30 $4,564
2014-03-31 $4,487
2013-12-31 $4,088
2013-09-30 $4,055
2013-06-30 $3,976
2013-03-31 $4,034
2012-12-31 $4,088
2012-09-30 $3,956
2012-06-30 $3,877
2012-03-31 $3,798
2011-12-31 $3,730
2011-09-30 $3,948
2011-06-30 $3,998
2011-03-31 $3,958
2010-12-31 $3,914
2010-09-30 $3,891
2010-06-30 $3,768
2010-03-31 $3,780
2009-12-31 $3,796
2009-09-30 $3,755
2009-06-30 $2,971
2009-03-31 $2,832
2008-12-31 $2,885
2008-09-30 $2,873
2008-06-30 $2,874
2008-03-31 $2,842
2007-12-31 $2,775
2007-09-30 $2,696
2007-06-30 $1,262
2007-03-31 $1,250
2006-12-31 $1,212
2006-09-30 $1,173
2006-06-30 $0
2006-03-31 $0
2005-12-31 $765
2005-09-30 $740
2005-06-30 $733
2005-03-31 $711
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.663B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $149.087B 10.34
Amgen (AMGN) United States $138.330B 14.93
CSL (CSLLY) Australia $104.641B 0.00
Gilead Sciences (GILD) United States $84.306B 8.97
Moderna (MRNA) United States $81.297B 161.98
Illumina (ILMN) United States $66.481B 95.86
Biogen (BIIB) United States $57.741B 13.22
Regeneron Pharmaceuticals (REGN) United States $57.109B 16.35
BioNTech SE (BNTX) Germany $51.734B 37.51
Vertex Pharmaceuticals (VRTX) United States $48.760B 20.08
Alexion Pharmaceuticals (ALXN) United States $39.777B 15.11
BeiGene (BGNE) Cayman Islands $30.286B 0.00
Genmab (GMAB) Denmark $28.565B 33.49
Seagen (SGEN) United States $27.835B 48.08
Genmab (GNMSF) Denmark $27.247B 6.27
Exact Sciences (EXAS) United States $21.770B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.710B 26.48
Alnylam Pharmaceuticals (ALNY) United States $20.247B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Incyte (INCY) United States $18.282B 36.14
Bio-Techne Corp (TECH) United States $17.314B 91.04
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
ARGENX SE-ADR (ARGX) Netherlands $16.157B 0.00
Zai Lab (ZLAB) China $15.289B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.164B 138.30
Novavax (NVAX) United States $13.329B 0.00
Guardant Health (GH) United States $12.508B 0.00
Repligen (RGEN) United States $10.961B 98.83
CureVac (CVAC) Germany $10.809B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.643B 0.00
Denali Therapeutics (DNLI) United States $9.066B 325.26
Mirati Therapeutics (MRTX) United States $8.573B 0.00
Fate Therapeutics (FATE) United States $7.919B 0.00
Acceleron Pharma (XLRN) United States $7.728B 0.00
Ascendis Pharma (ASND) Denmark $7.428B 0.00
Exelixis (EXEL) United States $6.935B 110.65
Ultragenyx Pharmaceutical (RARE) United States $6.477B 0.00
Sarepta Therapeutics (SRPT) United States $6.389B 0.00
AbCellera Biologics (ABCL) $6.180B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.135B 0.00
Halozyme Therapeutics (HALO) United States $6.114B 33.55
Vir Biotechnology (VIR) United States $5.698B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.628B 20.39
Adaptive Biotechnologies (ADPT) United States $5.587B 0.00
Twist Bioscience (TWST) United States $5.547B 0.00
I-Mab (IMAB) China $5.407B 0.00
Beam Therapeutics (BEAM) United States $5.319B 0.00
Intellia Therapeutics (NTLA) United States $5.214B 0.00
Legend Biotech (LEGN) United States $5.155B 0.00
NeoGenomics (NEO) United States $5.139B 871.60
Reata Pharmaceuticals (RETA) United States $5.073B 0.00
Galapagos (GLPG) Belgium $4.984B 0.00
Blueprint Medicines (BPMC) United States $4.873B 14.84
Apellis Pharmaceuticals (APLS) United States $4.814B 0.00
Certara (CERT) United States $4.212B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.141B 0.00
Arena Pharmaceuticals (ARNA) United States $4.030B 0.00
Alkermes (ALKS) Ireland $3.962B 0.00
SpringWorks Therapeutics (SWTX) United States $3.893B 0.00
Arvinas (ARVN) United States $3.853B 0.00
Intra-Cellular Therapies (ITCI) United States $3.505B 0.00
Emergent Biosolutions (EBS) United States $3.382B 6.74
Berkeley Lights (BLI) United States $3.296B 0.00
Insmed (INSM) United States $3.025B 0.00
Vericel (VCEL) United States $2.827B 762.25
BAVARIAN NORDIC (BVNRY) Denmark $2.811B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.751B 0.00
Amicus Therapeutics (FOLD) United States $2.714B 0.00
MorphoSys AG (MOR) Germany $2.630B 0.00
Sorrento Therapeutics (SRNE) United States $2.492B 0.00
Editas Medicine (EDIT) United States $2.453B 0.00
ALX Oncology Holdings (ALXO) United States $2.426B 0.00
Heska (HSKA) United States $2.395B 1044.14
Myriad Genetics (MYGN) United States $2.363B 0.00
Morphic Holding (MORF) United States $2.342B 0.00
Instil Bio (TIL) United States $2.325B 0.00
Global Blood Therapeutics (GBT) United States $2.309B 0.00
Bluebird Bio (BLUE) United States $2.224B 0.00
Revance Therapeutics (RVNC) United States $2.197B 0.00
Bionano Genomics (BNGO) United States $2.192B 0.00
Prothena (PRTA) Ireland $2.152B 0.00
Kymera Therapeutics (KYMR) United States $2.146B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.135B 0.00
Ligand Pharmaceuticals (LGND) United States $2.128B 35.60
Seer (SEER) $2.069B 0.00
Amarin (AMRN) Ireland $1.946B 0.00
Seres Therapeutics (MCRB) United States $1.916B 0.00
Castle Biosciences (CSTL) United States $1.907B 0.00
Myovant Sciences (MYOV) United Kingdom $1.896B 0.00
Protagonist Therapeutics (PTGX) United States $1.896B 0.00
Atea Pharmaceuticals (AVIR) United States $1.891B 0.00
Inovio Pharmaceuticals (INO) United States $1.847B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.817B 0.00
PHARMA MAR SA (PHMMF) Spain $1.777B 0.00
Genetron Holdings (GTH) China $1.767B 0.00
Zymeworks (ZYME) Canada $1.763B 0.00
Alector (ALEC) United States $1.705B 0.00
Arcus Biosciences (RCUS) United States $1.688B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.640B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.626B 0.00
REGENXBIO (RGNX) United States $1.611B 0.00
C4 Therapeutics (CCCC) United States $1.602B 0.00
UniQure (QURE) Netherlands $1.588B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.585B 0.00
Cytokinetics (CYTK) United States $1.574B 0.00
NGM Biopharmaceuticals (NGM) United States $1.531B 0.00
PureTech Health (PRTC) United States $1.462B 0.00
Avid Bioservices (CDMO) United States $1.442B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.372B 0.00
Zealand Pharma (ZEAL) Denmark $1.348B 0.00
MiMedx (MDXG) United States $1.342B 0.00
Nurix Therapeutics (NRIX) United States $1.316B 0.00
Northwest Biotherapeutics (NWBO) United States $1.316B 0.00
Precigen (PGEN) United States $1.313B 0.00
Ocugen (OCGN) United States $1.296B 0.00
BioAtla (BCAB) United States $1.292B 0.00
Codexis (CDXS) United States $1.267B 0.00
Repare Therapeutics (RPTX) Canada $1.255B 0.00
Shattuck Labs (STTK) United States $1.245B 0.00
Keros Therapeutics (KROS) United States $1.224B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.201B 0.00
Agenus (AGEN) United States $1.183B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.123B 0.00
Celldex Therapeutics (CLDX) United States $1.109B 0.00
MannKind (MNKD) United States $1.106B 0.00
Pliant Therapeutics (PLRX) United States $1.096B 0.00
Coherus BioSciences (CHRS) United States $1.089B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.086B 34.30
Mesoblast (MESO) Australia $1.081B 0.00
Scholar Rock Holding (SRRK) United States $1.061B 0.00
Dynavax Technologies (DVAX) United States $1.036B 0.00
Prometheus Biosciences (RXDX) United States $1.034B 0.00
Avidity Biosciences (RNA) United States $1.008B 0.00
VBI Vaccines (VBIV) United States $1.004B 0.00
Mersana Therapeutics (MRSN) United States $0.998B 0.00
Inhibrx (INBX) United States $0.979B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.944B 0.00
Travere Therapeutics (TVTX) United States $0.929B 0.00
G1 THERAPEUTICS (GTHX) United States $0.924B 0.00
Epizyme (EPZM) United States $0.898B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.892B 0.00
Cel-Sci (CVM) United States $0.885B 0.00
Sutro Biopharma (STRO) United States $0.864B 0.00
RAPT THERAPTICS (RAPT) United States $0.835B 0.00
Nkarta (NKTX) United States $0.832B 0.00
Verastem (VSTM) United States $0.820B 0.00
Merus (MRUS) Netherlands $0.805B 0.00
Affimed (AFMD) Germany $0.792B 0.00
SESEN BIO, INC (SESN) United States $0.780B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
IDEAYA Biosciences (IDYA) United States $0.748B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.744B 0.00
Pharming Group (PHAR) Netherlands $0.740B 0.00
Cara Therapeutics (CARA) United States $0.733B 63.70
Kadmon Holdings (KDMN) United States $0.719B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.715B 0.00
Curis (CRIS) United States $0.698B 0.00
Clene (CLNN) United States $0.690B 0.00
Cellectis S.A (CLLS) France $0.687B 0.00
DBV Technologies S.A (DBVT) France $0.687B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.684B 0.00
AnaptysBio (ANAB) United States $0.683B 0.00
ChromaDex (CDXC) United States $0.679B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.671B 0.00
MeiraGTx Holdings (MGTX) United States $0.665B 0.00
ALBIREO PHARMA (ALBO) United States $0.655B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.655B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.650B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Clovis Oncology (CLVS) United States $0.637B 0.00
Precision BioSciences (DTIL) United States $0.613B 0.00
Adagene (ADAG) China $0.609B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.599B 0.00
Anika Therapeutics (ANIK) United States $0.591B 0.00
Bolt Biotherapeutics (BOLT) United States $0.583B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.582B 0.00
Selecta Biosciences (SELB) United States $0.563B 0.00
Inventiva S.A (IVA) France $0.562B 0.00
Codiak BioSciences (CDAK) United States $0.552B 0.00
AC Immune SA (ACIU) Switzerland $0.541B 0.00
Forte Biosciences (FBRX) United States $0.540B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.537B 0.00
Compugen (CGEN) Israel $0.534B 0.00
Starpharma Holdings (SPHRY) Australia $0.506B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.496B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Gritstone Bio (GRTS) United States $0.487B 0.00
XBiotech (XBIT) United States $0.486B 0.00
CytomX Therapeutics (CTMX) United States $0.466B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.460B 0.00
Athenex (ATNX) United States $0.454B 0.00
Oncobiologics (OTLK) United States $0.451B 0.00
Spero Therapeutics (SPRO) United States $0.450B 0.00
Geron (GERN) United States $0.449B 0.00
BeyondSpring (BYSI) United States $0.443B 0.00
Neoleukin Therapeutics (NLTX) United States $0.434B 0.00
AquaBounty Technologies (AQB) United States $0.423B 0.00
Amryt Pharma (AMYT) United Kingdom $0.421B 0.00
ANI Pharmaceuticals (ANIP) United States $0.417B 11.51
Kindred Biosciences (KIN) United States $0.416B 0.00
Cue Biopharma (CUE) United States $0.412B 0.00
Puma Biotechnology (PBYI) United States $0.412B 0.00
Opthea (OPT) Australia $0.395B 0.00
Angion Biomedica (ANGN) United States $0.395B 0.00
SQZ Biotechnologies (SQZ) United States $0.384B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.382B 0.00
Kala Pharmaceuticals (KALA) United States $0.380B 0.00
Adverum Biotechnologies (ADVM) United States $0.365B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.361B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
BioDelivery Sciences (BDSI) United States $0.355B 14.40
UROGEN PHARMA (URGN) United States $0.351B 0.00
Fortress Biotech (FBIO) United States $0.350B 0.00
Cogent Biosciences (COGT) United States $0.349B 0.00
Syros Pharmaceuticals (SYRS) United States $0.348B 0.00
XOMA (XOMA) United States $0.347B 162.16
Frequency Therapeutics (FREQ) United States $0.347B 0.00
Athersys (ATHX) United States $0.344B 0.00
Theratechnologies (THTX) Canada $0.341B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
Cerecor (CERC) United States $0.336B 0.00
IBio (IBIO) United States $0.335B 0.00
Adicet Bio (ACET) United States $0.334B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.320B 0.00
Arbutus Biopharma (ABUS) United States $0.314B 0.00
Trevena (TRVN) United States $0.311B 0.00
OVID THERAPEUTC (OVID) United States $0.302B 2.97
CorMedix Inc (CRMD) United States $0.299B 0.00
Cardiff Oncology (CRDF) United States $0.294B 0.00
Innate Pharma S.A (IPHA) France $0.293B 0.00
Kaleido Biosciences (KLDO) $0.287B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Fulcrum Therapeutics (FULC) United States $0.280B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.276B 0.00
Bellus Health (BLU) Canada $0.268B 0.00
Clearside Biomedical (CLSD) United States $0.267B 0.00
Talis Biomedical (TLIS) United States $0.261B 0.00
INmune Bio (INMB) United States $0.260B 0.00
Kamada (KMDA) Israel $0.257B 17.51
HOOKIPA Pharma (HOOK) United States $0.252B 0.00
Seelos Therapeutics (SEEL) United States $0.248B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.241B 0.00
Chiasma (CHMA) United States $0.239B 0.00
ADMA Biologics Inc (ADMA) United States $0.229B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.228B 0.00
Synlogic (SYBX) United States $0.227B 0.00
NextCure (NXTC) United States $0.226B 0.00
Checkpoint Therapeutics (CKPT) United States $0.223B 0.00
Aptinyx (APTX) United States $0.222B 0.00
TELA Bio (TELA) United States $0.217B 0.00
VTv Therapeutics (VTVT) United States $0.200B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.192B 0.00
Biofrontera AG (BFRA) Germany $0.189B 0.00
Applied Genetic Technologies (AGTC) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.182B 0.00
PHASEBIO PHARMA (PHAS) United States $0.181B 0.00
Voyager Therapeutics (VYGR) United States $0.175B 4.51
VolitionRX (VNRX) United States $0.175B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.174B 0.00
Galena Biopharma (SLS) United States $0.173B 0.00
ObsEva SA (OBSV) Switzerland $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Eton Pharmaceuticals (ETON) United States $0.154B 0.00
Antibe Therapeutics (ATBPF) Canada $0.153B 0.00
DiaMedica Therapeutics (DMAC) United States $0.150B 0.00
Cyclerion Therapeutics (CYCN) United States $0.149B 0.00
Exicure (XCUR) United States $0.147B 0.00
Enzo Biochem (ENZ) United States $0.141B 41.43
Eyenovia (EYEN) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.139B 0.00
Novogen (KZIA) Australia $0.137B 0.00
Longeveron (LGVN) United States $0.135B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.134B 0.00
LogicBio Therapeutics (LOGC) United States $0.132B 0.00
Palatin Technologies (PTN) United States $0.132B 0.00
Erytech Pharma SA (ERYP) France $0.132B 0.00
ABVC BioPharma (ABVC) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.127B 0.00
Aptevo Therapeutics (APVO) United States $0.126B 0.00
Yumanity Therapeutics (YMTX) United States $0.126B 0.00
Aytu BioPharma (AYTU) United States $0.125B 0.00
Liminal BioSciences (LMNL) Canada $0.125B 0.00
Pluristem Therapeutics (PSTI) Israel $0.124B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.124B 0.00
Entera Bio (ENTX) Israel $0.123B 0.00
Evofem Biosciences (EVFM) United States $0.119B 0.00
Orgenesis (ORGS) United States $0.119B 243.50
Beyond Air (XAIR) United States $0.117B 0.00
Vyant Bio (VYNT) United States $0.115B 0.00
Celsion (CLSN) United States $0.114B 0.00
Vascular Biogenics (VBLT) Israel $0.112B 0.00
AEterna Zentaris (AEZS) United States $0.110B 0.00
Zosano Pharma (ZSAN) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.104B 0.00
Leap Therapeutics (LPTX) United States $0.103B 0.00
CytRx (CYTR) United States $0.103B 0.00
TRACON Pharmaceuticals (TCON) United States $0.102B 0.00
ARAVIVE, INC (ARAV) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.101B 0.00
Evogene (EVGN) Israel $0.097B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Protalix BioTherapeutics (PLX) Israel $0.093B 0.00
AIkido Pharma (AIKI) United States $0.090B 0.00
Lumos Pharma (LUMO) United States $0.090B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.089B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.085B 0.00
BioCardia (BCDA) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
Adocia (ADOCY) France $0.077B 0.00
ARIDIS PHARMACT (ARDS) United States $0.076B 0.00
Edesa Biotech (EDSA) Canada $0.076B 0.00
Celyad SA (CYAD) Belgium $0.075B 0.00
Cleveland BioLabs (CBLI) United States $0.075B 0.00
ATyr Pharma (LIFE) United States $0.075B 0.00
Viridian Therapeutics (VRDN) United States $0.072B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
Cyclo Therapeutics (CYTH) United States $0.067B 0.00
Genetic Technologies (GENE) Australia $0.063B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Pulmatrix (PULM) United States $0.059B 0.00
Windtree Therapeutics (WINT) United States $0.058B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.057B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.052B 0.00
Soligenix (SNGX) United States $0.048B 0.00
Enveric Biosciences (ENVB) United States $0.048B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 1.11
Invo BioScience (INVO) United States $0.046B 0.00
Timber Pharmaceuticals (TMBR) United States $0.043B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
GeoVax Labs (GOVX) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Benitec Biopharma (BNTC) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
Vallon Pharmaceuticals (VLON) United States $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
ZIVO Bioscience (ZIVO) United States $0.024B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00